Somatic inactivation of Pkd2 results in polycystic kidney disease

  • Wu, GQ
  • D'Agati, V
  • Cai, YQ
  • Markowitz, G
  • Park, JH
  • 외 6명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

480

초록

Germline mutations in PKD2 cause autosomal dominant polycystic kidney disease. We have introduced a mutant exon 1 in tandem with the wild-type exon 1 at the mouse Pkd2 locus. This is an unstable allele that undergoes somatic inactivation by intragenic homologous recombination to produce a true null allele. Mice heterozygous and homozygous for this mutation, as well as Pkd(+/-) mice, develop polycystic kidney and liver lesions that are indistinguishable from the human phenotype. In all cases, renal cysts arise from renal tubular cells that lose the capacity to produce Pkd2 protein. Somatic loss of Pkd2 expression is both necessary and sufficient for renal cyst formation in ADPKD, suggesting that PKD2 occurs by a cellular recessive mechanism.

키워드

PROTEINGENECELLSPATTERNENCODESPRODUCTADULTFETAL
제목
Somatic inactivation of Pkd2 results in polycystic kidney disease
저자
Wu, GQD'Agati, VCai, YQMarkowitz, GPark, JHReynolds, DMMaeda, YLe, TCKucherlapati, REdelmann, WSomlo, S
DOI
10.1016/S0092-8674(00)81570-6
발행일
1998-04
저널명
Cell
93
2
페이지
177 ~ 188